COYA 303 is an investigational proprietary combination of LD-IL-2 and GLP-1RA for subcutaneous administration, under development for the treatment of diseases, including Alzheimer's Disease, driven by ...
A collaborative initiative with American Nutraceutical Corp. advancing structured models of neural adaptation and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results